Farms.com Home   News

Richardson Aquires Bison Transport

James Richardson & Sons, Limited (JRSL) and Wescan Capital Inc. have announced that, effective January 1, 2021, JRSL acquired 100 per cent of the issued and outstanding shares of Bison Transport Inc. and its affiliated companies (Bison).
 
Bison is a Winnipeg-headquartered transportation company established in 1969 by Duncan M. Jessiman, which has grown to become one of Canada's largest trucking companies with over 3,700 employees and contractors operating a fleet of 2,100 tractors and 6,000 trailers throughout North America. Together with its affiliated companies, H.O. Wolding, Searcy Trucking and Britton Transport, Bison services a wide variety of multinational, national and local customers.
 
The transfer of ownership from Wescan to JRSL will not result in any changes to Bison's operations, nor to the "Bison" brand.
 
Bison will continue to be headquartered in Winnipeg.
 
Financial details of the transaction will not be made public.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.